These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21357785)

  • 1. Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study.
    Kurita GP; Sjøgren P; Ekholm O; Kaasa S; Loge JH; Poviloniene I; Klepstad P
    J Clin Oncol; 2011 Apr; 29(10):1297-303. PubMed ID: 21357785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in cancer pain patients receiving opioids: a pilot study.
    Kurita GP; de Mattos Pimenta CA
    Cancer Nurs; 2008; 31(1):49-57. PubMed ID: 18176132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of side effects of prolonged low or moderate dose opioid therapy with concomitant benzodiazepine and/or antidepressant therapy in chronic non-cancer pain.
    Manchikanti L; Manchikanti KN; Pampati V; Cash KA
    Pain Physician; 2009; 12(1):259-67. PubMed ID: 19165308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
    Lundorff L; Peuckmann V; Sjøgren P
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index.
    Mitera G; Zeiadin N; Kirou-Mauro A; DeAngelis C; Wong J; Sanjeevan T; Sinclair E; Danjoux C; Barnes E; Tsao M; Sahgal A; Chow E
    J Pain Symptom Manage; 2010 Feb; 39(2):259-67. PubMed ID: 20152589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-related bowel dysfunction: prevalence and identification of predictive factors in a large sample of Italian patients on chronic treatment.
    Rosti G; Gatti A; Costantini A; Sabato AF; Zucco F
    Eur Rev Med Pharmacol Sci; 2010 Dec; 14(12):1045-50. PubMed ID: 21375137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is oxycodone efficacy reflected in serum concentrations? A multicenter, cross-sectional study in 456 adult cancer patients.
    Andreassen TN; Klepstad P; Davies A; Bjordal K; Lundström S; Kaasa S; Dale O
    J Pain Symptom Manage; 2012 Apr; 43(4):694-705. PubMed ID: 22285284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of opioid requirements and analgesic response in opioid-tolerant versus opioid-naïve patients after total knee arthroplasty.
    Patanwala AE; Jarzyna DL; Miller MD; Erstad BL
    Pharmacotherapy; 2008 Dec; 28(12):1453-60. PubMed ID: 19025426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation and cognitive dysfunction in opioid-treated patients with cancer.
    Kurita GP; Ekholm O; Kaasa S; Klepstad P; Skorpen F; Sjøgren P
    Brain Behav; 2016 Jul; 6(7):e00471. PubMed ID: 27247849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function in patients with chronic pain treated with opioids: characteristics and associated factors.
    Kurita GP; de Mattos Pimenta CA; Braga PE; Frich L; Jørgensen MM; Nielsen PR; Højsted J; Sjøgren P
    Acta Anaesthesiol Scand; 2012 Nov; 56(10):1257-66. PubMed ID: 22946710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes after intravenous opioids in emergency patients: a prospective cohort analysis.
    O'Connor AB; Zwemer FL; Hays DP; Feng C
    Acad Emerg Med; 2009 Jun; 16(6):477-87. PubMed ID: 19426295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive functioning in patients with cerebral aneurysms measured with the mini mental state examination and the telephone interview for cognitive status.
    King JT; DiLuna ML; Cicchetti DV; Tsevat J; Roberts MS
    Neurosurgery; 2006 Oct; 59(4):803-10; discussion 810-1. PubMed ID: 17038944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological assessment of chronic non-malignant pain patients treated in a multidisciplinary pain centre.
    Sjøgren P; Christrup LL; Petersen MA; Højsted J
    Eur J Pain; 2005 Aug; 9(4):453-62. PubMed ID: 15979026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid use for chronic low back pain: A prospective, population-based study among injured workers in Washington state, 2002-2005.
    Franklin GM; Rahman EA; Turner JA; Daniell WE; Fulton-Kehoe D
    Clin J Pain; 2009; 25(9):743-51. PubMed ID: 19851153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.